P53 Activates Transcription by Directing Structural Shifts in Mediator

Overview

Journal Nat Struct Mol Biol

Specialties Cell Biology
Molecular Biology

Date 2010 May 11

PMID 20453859

Citations 83

Authors

Krista D Meyer

Shih-Chieh Lin

Carrie Bernecky

Yuefeng Gao

Dylan J Taatjes

Affiliations

Soon will be listed here.

Abstract

It is not well understood how the human Mediator complex, transcription factor IIH and RNA polymerase II (Pol II) work together with activators to initiate transcription. Activator binding alters Mediator structure, yet the functional consequences of such structural shifts remain unknown. The p53 C terminus and its activation domain interact with different Mediator subunits, and we find that each interaction differentially affects Mediator structure; strikingly, distinct p53-Mediator structures differentially affect Pol II activity. Only the p53 activation domain induces the formation of a large pocket domain at the Mediator-Pol II interaction site, and this correlates with activation of stalled Pol II to a productively elongating state. Moreover, we define a Mediator requirement for TFIIH-dependent Pol II C-terminal domain phosphorylation and identify substantial differences in Pol II C-terminal domain processing that correspond to distinct p53-Mediator structural states. Our results define a fundamental mechanism by which p53 activates transcription and suggest that Mediator structural shifts trigger activation of stalled Pol II complexes.

Citing Articles

Multi-omics and biochemical reconstitution reveal CDK7-dependent mechanisms controlling RNA polymerase II function at gene 5'- and 3'-ends.

Luyties O, Sanford L, Rodino J, Nagel M, Jones T, Rimel J bioRxiv. 2025; .

PMID: 39829884 PMC: 11741307. DOI: 10.1101/2025.01.08.632016.

Real-time visualization of reconstituted transcription reveals RNA polymerase II activation mechanisms at single promoters.

Palacio M, Taatjes D bioRxiv. 2025; .

PMID: 39829877 PMC: 11741285. DOI: 10.1101/2025.01.06.631569.

Distinct effects of CDK8 module subunits on cellular growth and proliferation in Drosophila.

Li X, Liu M, Xing Y, Niu Y, Liu T, Sun J Development. 2024; 151(23).

PMID: 39531377 PMC: 11634032. DOI: 10.1242/dev.203111.

Studying RNA Polymerase II Promoter-Proximal Pausing by In Vitro Immobilized Template and Transcription Assays.

Bunch H Methods Mol Biol. 2023; 2693:13-24.

PMID: 37540423 DOI: 10.1007/978-1-0716-3342-7_2.

Interaction modules that impart specificity to disordered protein.

Cermakova K, Hodges H Trends Biochem Sci. 2023; 48(5):477-490.

PMID: 36754681 PMC: 10106370. DOI: 10.1016/j.tibs.2023.01.004.

References

Okorokov A, Sherman M, Plisson C, Grinkevich V, Sigmundsson K, Selivanova G . The structure of p53 tumour suppressor protein reveals the basis for its functional plasticity. EMBO J. 2006; 25(21):5191-200. PMC: 1630404. DOI: 10.1038/sj.emboj.7601382. View

Davis J, Takagi Y, Kornberg R, Asturias F . Structure of the yeast RNA polymerase II holoenzyme: Mediator conformation and polymerase interaction. Mol Cell. 2002; 10(2):409-15. DOI: 10.1016/s1097-2765(02)00598-1. View

Ito M, Yuan C, Malik S, Gu W, Fondell J, Yamamura S . Identity between TRAP and SMCC complexes indicates novel pathways for the function of nuclear receptors and diverse mammalian activators. Mol Cell. 1999; 3(3):361-70. DOI: 10.1016/s1097-2765(00)80463-3. View

Johnson K, Wang J, Smallwood A, Arayata C, Carey M . TFIID and human mediator coactivator complexes assemble cooperatively on promoter DNA. Genes Dev. 2002; 16(14):1852-63. PMC: 186393. DOI: 10.1101/gad.995702. View

Taatjes D, Naar A, Andel 3rd F, Nogales E, Tjian R . Structure, function, and activator-induced conformations of the CRSP coactivator. Science. 2002; 295(5557):1058-62. DOI: 10.1126/science.1065249. View

Keaveney M, Struhl K . Activator-mediated recruitment of the RNA polymerase II machinery is the predominant mechanism for transcriptional activation in yeast. Mol Cell. 1998; 1(6):917-24. DOI: 10.1016/s1097-2765(00)80091-x. View

Kornberg R . Mediator and the mechanism of transcriptional activation. Trends Biochem Sci. 2005; 30(5):235-9. DOI: 10.1016/j.tibs.2005.03.011. View

Glover-Cutter K, Kim S, Espinosa J, Bentley D . RNA polymerase II pauses and associates with pre-mRNA processing factors at both ends of genes. Nat Struct Mol Biol. 2007; 15(1):71-8. PMC: 2836588. DOI: 10.1038/nsmb1352. View

Ventura A, Kirsch D, McLaughlin M, Tuveson D, Grimm J, Lintault L . Restoration of p53 function leads to tumour regression in vivo. Nature. 2007; 445(7128):661-5. DOI: 10.1038/nature05541. View

10.

Xiao H, Pearson A, Coulombe B, Truant R, Zhang S, Regier J . Binding of basal transcription factor TFIIH to the acidic activation domains of VP16 and p53. Mol Cell Biol. 1994; 14(10):7013-24. PMC: 359231. DOI: 10.1128/mcb.14.10.7013-7024.1994. View

11.

Fondell J, Ge H, Roeder R . Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex. Proc Natl Acad Sci U S A. 1996; 93(16):8329-33. PMC: 38670. DOI: 10.1073/pnas.93.16.8329. View

12.

Di Lello P, Miller Jenkins L, Jones T, Nguyen B, Hara T, Yamaguchi H . Structure of the Tfb1/p53 complex: Insights into the interaction between the p62/Tfb1 subunit of TFIIH and the activation domain of p53. Mol Cell. 2006; 22(6):731-740. DOI: 10.1016/j.molcel.2006.05.007. View

13.

Yang F, deBeaumont R, Zhou S, Naar A . The activator-recruited cofactor/Mediator coactivator subunit ARC92 is a functionally important target of the VP16 transcriptional activator. Proc Natl Acad Sci U S A. 2004; 101(8):2339-44. PMC: 356952. DOI: 10.1073/pnas.0308676100. View

14.

Johnson K, Wang J, Smallwood A, Carey M . The immobilized template assay for measuring cooperativity in eukaryotic transcription complex assembly. Methods Enzymol. 2004; 380:207-19. DOI: 10.1016/S0076-6879(04)80010-7. View

15.

Jimenez G, Nister M, Stommel J, Beeche M, Barcarse E, Zhang X . A transactivation-deficient mouse model provides insights into Trp53 regulation and function. Nat Genet. 2000; 26(1):37-43. DOI: 10.1038/79152. View

16.

Momand J, Zambetti G, Olson D, George D, Levine A . The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell. 1992; 69(7):1237-45. DOI: 10.1016/0092-8674(92)90644-r. View

17.

De Carlo S, El-Bez C, Borge J, Dubochet J . Cryo-negative staining reduces electron-beam sensitivity of vitrified biological particles. J Struct Biol. 2002; 138(3):216-26. DOI: 10.1016/s1047-8477(02)00035-7. View

18.

Wang G, Balamotis M, Stevens J, Yamaguchi Y, Handa H, Berk A . Mediator requirement for both recruitment and postrecruitment steps in transcription initiation. Mol Cell. 2005; 17(5):683-94. DOI: 10.1016/j.molcel.2005.02.010. View

19.

Maier B, Gluba W, Bernier B, Turner T, Mohammad K, Guise T . Modulation of mammalian life span by the short isoform of p53. Genes Dev. 2004; 18(3):306-19. PMC: 338283. DOI: 10.1101/gad.1162404. View

20.

Vousden K, Prives C . Blinded by the Light: The Growing Complexity of p53. Cell. 2009; 137(3):413-31. DOI: 10.1016/j.cell.2009.04.037. View